We are live on ! Find out more
BCDA icon

BioCardia
BCDA

16 hedge funds and large institutions have $5.96M invested in BioCardia in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,366% more capital inflows, than outflows

Capital inflows: $1.72M | Capital outflows: $118K

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

100% more funds holding

Funds holding: 8 → 16 (+8)

1.59% more ownership

Funds ownership: 9.01% → 10.59% (+1.6%)

Holders
16
Holders Change
+8
Holders Change %
+100%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RAM
Roumell Asset Management
Maryland
+$618K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$255K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$60.1K
4
Northern Trust
Northern Trust
Illinois
+$47.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$44.2K

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$118K

BCDA Hedge Fund Activity: Q4 2020 in Review

16 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q4 2020, worth a combined $5.96M — up 127% from $2.62M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BCDA positions and 1 closed out — a net gain of 8 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Roumell Asset Management, adding an estimated $618K. The largest seller was Osaic Holdings, cutting an estimated $118K.

  • 16 institutional investors held BioCardia (BCDA) as of Q4 2020, up from 8 in Q3 2020.
  • Funds reported $5.96M of BioCardia stock for Q4 2020, up 127% quarter-over-quarter.
  • 9 funds opened new BioCardia positions in Q4 2020 and 1 closed out, a net change of +8 holders.
  • The largest BioCardia buyer in Q4 2020 was Roumell Asset Management, an estimated $618K added.
  • The largest BioCardia seller in Q4 2020 was Osaic Holdings, an estimated $118K sold.

Based on aggregated 13F filings for Q4 2020.